Skip to content

Category: Research

Best Disease Gene Therapy Advances Toward Clinical Trial

Source: Foundation Fighting Blindness Blog – Eye on the Cure – Best Disease Gene Therapy Advances Toward Clinical Trial Audio version: Untreated retina Retina treated with gene therapy Using gene therapy, FFB-funded researchers at the University of Pennsylvania School of Veterinary Medicine (Penn Vet) and Perelman School of Medicine…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Choroideremia Gene Therapy Moves into Phase 3 Human Study

Source: Foundation Fighting Blindness Blog – Eye on the Cure – Choroideremia Gene Therapy Moves into Phase 3 Human Study Audio version: Nightstar Therapeutics, a retinal-disease, gene-therapy development company in the UK, is advancing its emerging gene therapy for choroideremia into a Phase 3 clinical trial known as STAR.…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

Natural History Study Launches for LCA Caused by Specific Mutation in CEP290

Source: Foundation Fighting Blindness Blog – Eye on the Cure – Natural History Study Launches for LCA Caused by Specific Mutation in CEP290 Massachusetts Eye and Ear (MEE) is participating in a natural history study for people with Leber congenital amaurosis (LCA) type 10 caused by a mutation referred…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest

FFB-CRI Investing $7.5 Million in Emerging Therapy for USH2A

Source: Foundation Fighting Blindness Blog – Eye on the Cure – FFB-CRI Investing .5 Million in Emerging Therapy for USH2A Audio version: The Foundation Fighting Blindness Clinical Research Institute (FFB-CRI) has entered into a partnership with ProQR to develop a retinal therapy for people with Usher syndrome type 2A…

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest